Alexander Kabanov, Ph. D., professor in the University of Nebraska Medical Center College of Pharmacy, has been named chairman of a National Institutes of Health (NIH) study section. The NIH is the world’s leading provider of financial support for medical and health research.
On July 1, Dr. Kabanov will begin his duties as chairman of the NIH Center for Scientific Review Biomaterials and Biointerfaces study section, a position he will hold for two years. Dr. Kabanov is an expert in polymer delivery who has done peer reviews for various government agencies.
Dr. Kabanov will lead the study section of 19 other scientists who represent institutions like Yale University, Stanford University and the University of Michigan. It is the responsibility of the study section to review nearly 4,500 grant proposals and attend three meetings throughout the year. The grants focus on the innovative materials used in medicines and biotechnology to improve health, Dr. Kabanov said.
He is intent on making a difference while serving as chairman. "We must discuss the grant proposals in good faith by making sure that they are fair and objective," Dr. Kabanov said. "It is essential that grant feedback assists the development of stronger proposals for better science. It is the chair’s job to keep it professional."
Clarence Ueda, Pharm.D., Ph.D., dean of the UNMC College of Pharmacy, said Dr. Kabanov’s appointment as chairman is a prestigious and coveted honor.
"It is a significant recognition to have a faculty member chair an NIH study section, not only good for the individual, but also for UNMC and the College of Pharmacy," Dr. Ueda said. "Dr. Kabanov is considered by his peers to be an exceptionally creative and gifted biomaterials scientist, and that is why he has been chosen as chairman to the study section. Dr. Kabanov is at the top of his game scientifically, and is still rising."
UNMC is the only public health science center in the state. Its educational programs are responsible for training more health professionals practicing in Nebraska than any other institution. Through its commitment to education, research, patient care and outreach, UNMC has established itself as one of the country’s leading centers in cancer, transplantation biology, bioterrorism preparedness, neurodegenerative diseases, cardiovascular diseases, genetics, biomedical technology, ophthalmology and arthritis. UNMC’s research funding from external sources is now more than $72 million annually and has resulted in the creation of nearly 2,400 highly skilled jobs in the state.